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Abstract
Bacterial effector proteins, which are delivered into the host cell via the type III secretion system, play a key role in the
pathogenicity of Gram-negative bacteria by modulating various host cellular processes to the benefit of the pathogen. To
identify cellular processes targeted by bacterial effectors, we developed a simple strategy that uses an array of yeast
deletion strains fitted into a single 96-well plate. The array is unique in that it was optimized computationally such that
despite the small number of deletion strains, it covers the majority of genes in the yeast synthetic lethal interaction network.
The deletion strains in the array are screened for hypersensitivity to the expression of a bacterial effector of interest. The
hypersensitive deletion strains are then analyzed for their synthetic lethal interactions to identify potential targets of the
bacterial effector. We describe the identification, using this approach, of a cellular process targeted by the Xanthomonas
campestris type III effector XopE2. Interestingly, we discover that XopE2 affects the yeast cell wall and the endoplasmic
reticulum stress response. More generally, the use of a single 96-well plate makes the screening process accessible to any
laboratory and facilitates the analysis of a large number of bacterial effectors in a short period of time. It therefore provides
a promising platform for studying the functions and cellular targets of bacterial effectors and other virulence proteins.
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Introduction
Gram-negative bacteria are the causal agents of numerous
diseases in plants and animals. Many of these bacteria encode a
syringe-like structure termed the type III secretion system, which
delivers effector proteins into the host cell during infection [1].
Once inside the host cell, these virulence proteins, named type III
effectors (T3Es), modulate various host cellular processes to the
benefit of the pathogen. T3Es were shown to target components of
the immune system, transcription, cell death, proteasome and
ubiquitination systems, RNA metabolism, hormone pathways and
chloroplast and mitochondria functions [2,3,4]. A current
challenge is to systematically determine the virulence functions,
biochemical activities and host targets of T3Es.
The yeast Saccharomyces cerevisiae has recently emerged as a tool to
investigate bacterial T3Es [5,6,7,8]. The use of yeast in the study
of bacterial effectors is based on the observation that these proteins
often target fundamental cellular processes that are conserved
among all eukaryotes. In agreement with this premise, the
expression of many T3Es from plant and animal pathogens
inhibits yeast growth [6,9]. Toxic phenotypes induced by bacterial
effectors in yeast were used in suppressor screens for the
identification of eukaryotic targets of the effectors [10,11].
Recently, Kramer et al. described an approach to study bacterial
effectors in yeast, which uses yeast synthetic lethal (SL) interaction
data [12]. Synthetic lethality is defined as the situation in which two
genes that are non-essential when individually mutated cause
lethality when they are combined as a double mutant [13]. Kramer
et al. systematically screened the yeast deletion strain collection for
strains that were hypersensitive to the expression of the Shigella T3E
OspF, a member of the phosphothreonine lyase family [14]. Their
analysis was based on the assumption that phenotypes resulting
from the activity of OspF would resemble phenotypes of a mutation
in the target gene of the effector. Therefore, there should be an
overlap between the deletion strains hypersensitive to the effector
and the SL interactions of the target gene. Accordingly, genes were
defined as congruent to an effector, if their sets of SL interactions
overlapped with the deletion strains hypersensitive to that effector
[12,15]. The congruent genes represent putative targets of the
effector. Kramer et al. combined the results from the screen with
yeast SL interaction data to identify genes congruent to OspF.
Analysis of the processes in which these congruent genes were
involved resulted in the identification of a cellular process that was
targeted by the effector. Although it can lead to the identification of
thecellulartargetsofT3Es, the majordisadvantage ofthis approach
is that it requires the screening of all 4,750 deletion strains, which
limits its wide application to laboratories that have the required
technology. Alternative methods, such as SLAM (synthetic lethality
analysis with microarrays) and diploid-based SLAM, allow for
identification of SL interactions in a single pool [16,17]. However,
the use of microarrays increases the complexity of the assay.
In this work, we present a simple strategy that uses yeast SL
interaction data to identify cellular processes that are affected by
the expression of bacterial T3Es. Our strategy is based on the
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27698finding that it is possible to cover the majority of the interacting
genes (i.e. genes having at least one known SL interaction) with 90
deletion strains. We show that an array of yeast deletion strains
fitted into a single 96-well plate covers 69% of the interacting
genes with less than 2% of the deletion strains in the yeast
collection. The small number of deletion strains in the array
simplifies the analysis, reduces costs and facilitates the screening of
a large number of bacterial T3Es in a short period of time.
The deletion strains are transformed with a galactose inducible
expression vector encoding the bacterial T3E of interest and
then screened to identify deletion strains that are hypersensitive to
the expression of the effector (a schematic representation of our
approach is shown in Figure 1). A centromere-containing vector is
used to obtain low-level expression of the bacterial T3E and thus
to increase the specificity of the assay [18]. The hypersensitive
deletion strains are then analyzed to identify genes congruent to
the bacterial effector. The pathways and processes enriched
among the congruent genes represent potential targets of the
bacterial effector. We describe the identification, using this
approach, of a yeast cellular process targeted by the Xanthomonas
campestris pv. vesicatoria T3E XopE2. Our approach can be easily
employed to characterize T3Es from plant and animal pathogens
as well as other virulence proteins that function inside the host cell.
Results
Ninety deletion strains are sufficient to cover the majority
of the yeast SL interaction network
The yeast SL interaction network contains 10,438 interactions
between 2,795 genes based on data extracted from the
Saccharomyces Genome Database. Our objective was to construct
a small array of deletion strains covering the yeast SL interaction
network and then use this array to identify cellular processes
affected by the expression of bacterial effectors (Fig. 1). Our first
goal was to evaluate the minimal number of haploid null deletion
strains required for maximal coverage of the yeast SL interaction
network. We were interested in two aspects. The first aspect was
the number of genes that were covered by the selected deletion
strains, and the second aspect was the number of genes that were
covered by two or more of the selected deletion strains, to ensure
some overlap between the deletion strains. Based on the notion
that the distribution of SL interactions between the genes was not
equal [13], we hypothesized that maximal coverage of the network
should not require the entire collection of deletion strains.
To evaluate the minimal number of deletion strains required
for maximal coverage of the SL interaction network, we
constructed a selection algorithm that iterated over the list of
viable null deletion strains and every time selected the deletion
strain that had the maximal contribution to the coverage of the
SL interaction network (according to SL interaction data
retrieved from the Saccharomyces Genome Database). Contribution
of a deletion strain was defined as the number of interacting
genes (i.e. genes having at least one known SL interaction) that
were not covered by the selected deletion strains or covered only
once. To increase the efficiency of the algorithm, we discarded
deletion strains with no SL interactions as they could not
contribute to the coverage of the network. In cases where two or
more deletion strains had the same contribution, the algorithm
selected one of them randomly. The algorithm continued
iterating over the list until the contribution of the next deletion
strain was zero, meaning that the selected deletion strains reached
maximal coverage of the network (Fig. 2). As expected, the first
deletion strains to be selected were those which interacted with
the largest number of genes (‘hub genes’). However, with the
progress of the selection process, deletion strains which interacted
with genes not covered by previously selected deletion strains (or
covered once) were favored over deletion strains which interacted
with a larger number of genes, but that were already covered.
The minimal number of deletion strains required for maximal
coverage was found to be 728 out of the 4,750 viable deletion
strains (,15.3%). Altogether, 2,360 interacting genes were
covered by the deletion strains, 1,478 of them were covered by
two or more deletion strains. Thus, maximal coverage of the yeast
SL interaction network required only a small subset of the
deletion strains.
Interestingly, our calculations indicated that the increase in
interacting genes was not linearly proportional to the number of
deletion strains (Fig. 2). In fact, it showed that 90 deletion strains
Figure 1. Schematic representation of the approach used in
this study. A yeast-based strategy to identify cellular processes
targeted by bacterial type III effectors using an array of deletion strains
in a single 96-well plate.
doi:10.1371/journal.pone.0027698.g001
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(dashed line in Fig. 2). This is because the first deletion strains to
be selected were hub genes interacting with many genes.
Therefore, a single 96-well plate is sufficient to cover the
majority of the interacting genes in the yeast SL interaction
network.
Constructing the array of deletion strains
Based on our finding that 90 deletion strains were sufficient to
cover the majority of the interacting genes (i.e. genes having at
least one known SL interaction) in the yeast SL interaction
network, we decided to limit the array of the deletion strains to a
single 96-well plate. This decision was driven by the premise that
it is much easier to screen a single 96-well plate than to screen
over fifty 96-well plates containing the entire yeast deletion strain
collection. Our original aim was to select 94 deletion strains,
leaving 2 wells for the wild-type strain. We preselected 4 deletion
strains of interest (Dhac1, Dire1, Dbck1 and Dslt2), and the other 90
deletion strains were selected computationally using the selection
algorithm described earlier. The algorithm was limited to 90
iterations over the list of viable deletion strains and was devised to
take into consideration the contribution of the 4 preselected
genes. We corroborated the results using the Genetic Algorithm,
an evolution-inspired optimization technique, which we em-
ployed in the past to determine the rate constants of chemical-
kinetic models [19,20,21] (see Text S1). We assessed the ability of
the selected deletion strains to grow properly on selective
synthetic media containing glucose and on synthetic media
containing galactose, which is used in our system to induce the
expression of the bacterial effector. Due to poor growth, several
deletion strains had to be substituted by other deletion strains
covering similar SL interactions or by copies of the wild-type
strain (see Text S1). The final 96-well plate contained 92 deletion
strains and 4 copies of the wild-type strain (Fig. S1 and Table S1).
Remarkably, the final array of the deletion strains, which used
less than 2% of the deletion strains in the yeast deletion strain
collection, covered 1,624 out of the 2,360 interacting genes in
yeast (,69%) with 833 interacting genes covered by two or more
deletion strains.
The array of deletion strains is sufficient to predict the
cellular target of OspF
We noted earlier that Kramer et al. identified the cellular
process targeted by the Shigella T3E OspF by screening the yeast
deletion strain collection for deletion strains hypersensitive to
OspF [12]. They showed that almost all of the genes congruent to
OspF (i.e. genes which have sets of SL interactions overlapping
with the deletion strains hypersensitive to the effector) encoded
proteins involved in either the cell wall integrity (CWI) pathway or
chitin biosynthesis, both of which are processes related to cell wall
biogenesis. These findings led to the conclusion that this bacterial
effector targeted the CWI pathway. We tested whether our
computationally selected array of deletion strains was sufficient to
predict the cellular target of OspF, as a proof of concept for our
small array approach. Examination of the 83 deletion strains that
were determined by Kramer et al. as hypersensitive to OspF
revealed that 9 of them were included in our array of deletion
strains (Dccr4, Dsmi1, Dlas21, Dfks1, Dgim5, Dgas1, Dbni1, Dkre1 and
Dpop2). Based on these deletion strains, we identified 13 genes that
were congruent to OspF (Table S2; see Text S1 for description of
the analysis). Encouragingly, 8 of the 13 congruent genes we
identified were also found by Kramer et al. [12]. Moreover,
analysis of the Gene Ontology (GO) attributes that were enriched
among the 13 congruent genes, which was performed using the
FuncAssociate 2.0 web application [22], revealed that the
congruent genes were indeed involved in processes related to cell
wall biogenesis (see Table S3), suggesting that OspF targeted this
cellular process. In conclusion, this result indicates that the array
of the deletion strains we constructed can be used to identify
processes affected by bacterial effectors, as an efficient alternative
to screening the entire yeast deletion strain collection.
XopE2 is predicted to target cell wall biogenesis and
organization
We next tested whether our approach could be used to predict
the cellular targets of bacterial T3Es for which no targets were
previously defined. The Xanthomonas campestris pv. vesicatoria T3E
XopE2 is a member of the HopX family of putative transgluta-
minases that was found to localize to the plasma membrane of
plant cells [23]. We used our array of deletion strains to elucidate
the cellular processes targeted by XopE2. First, we transformed
the array with the yeast galactose inducible expression vector
pGML10 [24] either empty or encoding XopE2. We picked the
transformed cells into round-bottom microtiter plates containing
repressing media and allowed them to grow to saturation. After
washing and diluting the saturated cells 1:10, we spotted the cells
on repressing and inducing media and screened them to identify
deletion strains that were hypersensitive to the expression of
XopE2 (a deletion strain was defined as hypersensitive to XopE2 if
the relative growth ratio of the strain was lower than 50% in at
least two of the three biological repetitions; see Text S1). Figure 3A
shows the various plates from one of three biological repetitions
after 2–3 days at 30uC. Figure 3B shows the quadruplicate spots of
the Dsmi1 deletion strain that was identified as hypersensitive to
XopE2. Altogether, we identified in the screen 8 hypersensitive
deletion strains (Dslt2, Dchs5, Dsmi1, Dswi4, Dcla4, Dswf1, Drad27
and Dnbp2). The hypersensitivity of these deletion strains to
XopE2 was validated using a spotting assay (Fig. S2).
Based on the deletion strains found to be hypersensitive to
XopE2, we identified 12 genes that were congruent to XopE2
(gas1, bni1, smi1, bem2, bck1, rvs167, spa2, skt5, myo2, chs5, chs3 and
slt2) (Table 1; see Text S1). We used the FuncAssociate 2.0 web
application [22], capable of identifying GO attributes enriched in
Figure 2. Coverage of the SL interaction network as a function
of the number of deletion strains. The selection algorithm iterates
over the list of viable deletion strains and every time selects the
deletion strain with the maximal contribution to the coverage of the SL
network. The selection process stops when the contribution of the next
deletion strains is zero. The graph shows the number of interacting
genes (i.e. genes having at least one known SL interaction) covered by
the deletion strains throughout the selection process. The dashed line
marks the coverage by the first 90 deletion strains.
doi:10.1371/journal.pone.0027698.g002
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these congruent genes (Table 2; see Table S4 for the congruent
genes associated with each GO attribute). Remarkably, the GO
attributes that were given the higher scores were all related to cell
wall biogenesis and organization. In fact, the 12 congruent genes
were all involved in cell wall biogenesis and organization,
suggesting that XopE2 affects these processes in yeast. Interest-
ingly, 8 out of the 12 congruent genes were also involved in
endoplasmic reticulum (ER)-nucleus signaling pathway (Table 2).
XopE2 causes sensitivity to the cell wall stressing agents
caffeine and SDS
The results from the screen prompted us to investigate the effect
of XopE2 on the yeast cell wall. We tested the sensitivity of yeast
cells expressing XopE2 to a series of cell wall stressing agents,
including caffeine, sodium dodecyl sulphate (SDS), calcofluor
white and Congo red [25,26,27,28]. As shown in Figure 4, yeast
cells expressing XopE2 were sensitive to two cell wall stressing
agents, caffeine and SDS, suggesting that XopE2 affected the yeast
cell wall. We noted earlier that the Shigella T3E OspF affected the
yeast cell wall by inhibiting the CWI pathway. Therefore, we were
intrigued to test whether XopE2 also affected the activation of this
pathway. To this end, we monitored the activity of a lacZ reporter
driven by a CWI pathway responsive element in response to
caffeine, which was previously shown to activate the CWI pathway
[29]. As shown in Figure 5, the caffeine-dependent activation of
the reporter was not significantly affected by XopE2, suggesting
that XopE2 does not directly target the CWI pathway. Hence, it is
possible that XopE2 targets a different process related to cell wall
biogenesis and organization.
XopE2 affects the ER stress response
The results of our screen indicated that 8 out of the 12 genes
that were identified as congruent to XopE2 were involved in ER-
nucleus signaling pathway. This GO attribute was defined by the
GO consortium as: ‘‘Any series of molecular signals that conveys
information from the ER to the nucleus, usually resulting in a
change in transcriptional regulation’’ [30]. The most studied ER-
nucleus signaling pathway is the unfolded protein response (UPR),
Figure 3. Screen for deletion strains hypersensitive to XopE2.
A, The deletion strains in the array were transformed with pGML10,
either empty or encoding XopE2, and were spotted in quadruplicates
on repressing (2% glucose) and inducing (2% galactose and 1%
raffinose) media. The plates were scanned after 2–3 days at 30uCt o
quantify growth. B, Quadruplicate spots of the Dsmi1 deletion strain
from the screen described in A.
doi:10.1371/journal.pone.0027698.g003
Table 1. Genes identified as congruent to XopE2.
slt2 chs5 smi1 swi4 cla4 swf1 rad27 nbp2 SL Overlap
a Total SL
b p-value Score
c
gas1 +++ + + + 6 16 8.8E-12 11.1
bni1 +++ ++ + 6 18 2.0E-11 10.7
smi1 ++ +++ + 6 22 2.1E-11 10.7
bem2 +++ ++ 5 14 1.2E-09 8.9
bck1 +++ ++ 5 14 1.2E-09 8.9
rvs167 +++ ++ 5 18 5.0E-09 8.3
spa2 ++ + + 4 7 8.4E-09 8.1
skt5 ++ + + 4 8 1.7E-08 7.8
myo2 +++ + 4 8 1.7E-08 7.8
chs5 ++ + + 4 10 2.5E-08 7.6
chs3 ++ + + 4 9 3.0E-08 7.5
slt2 ++ ++ 4 13 8.6E-08 7.1
A plus sign marks an SL interaction between a congruent gene and a deletion strain hypersensitive to XopE2.
aSL Overlap - the number of SL interactions with hypersensitive deletion strains.
bTotal SL - the number of SL interactions with the deletion strains in the array.
cScore - Congruence score; the negative logarithm (base 10) of the p-value.
doi:10.1371/journal.pone.0027698.t001
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overload of unfolded proteins in the ER [31,32,33]. Interestingly,
uncompensated ER stress and mutations in the UPR activator Ire1
were shown to cause alteration in cell wall structure, indicating
that the UPR is required for cell wall organization and biogenesis
[34,35]. To determine whether XopE2 affects the ER stress
response, we tested the sensitivity of yeast cells expressing XopE2
to tunicamycin, a specific inhibitor of N-linked glycosylation in the
ER. We found that cells expressing XopE2 were highly sensitive to
tunicamycin (Fig. 6A, upper panels). Furthermore, cells expressing
XopE2 were also sensitive to 2-deoxy-D-glucose (Fig. 6A, lower
panels), an inhibitor of D-mannose incorporation into the
dolicholpyrophosphate-bound core oligosaccharide, which causes
undergylcosylation of nascent polypeptide chains in the ER [36].
We next tested the ability of yeast cells expressing XopE2 to
activate the UPR in response to ER stress. We monitored the
expression of a lacZ reporter driven by a UPR responsive element
in response to the reducing agent dithiothreitol (DTT), which is
known to induce ER stress [37]. Remarkably, expression of
XopE2 attenuated the activation of the lacZ reporter in response to
DTT to 40% compared with the activation seen in yeast
containing an empty expression vector (Fig. 6B). Altogether, these
results suggest that XopE2 affects the ER stress response, linking
XopE2 to cell wall organization and biogenesis. To the best of our
knowledge, this is the first report of a bacterial effector affecting
the ER stress response. The exact mechanism by which XopE2 is
operating remains to be elucidated.
Discussion
In this work, we describe a simple strategy that employs an
array of yeast deletion strains to identify cellular processes
targeted by virulence proteins. Our strategy is based on the
observation that maximal coverage of the yeast SL interaction
network does not require the entire collection of null deletion
strains. The major advantage of this strategy is that it uses a single
96-well plate instead of over fifty 96-well plates that are used
when the entire yeast deletion strain collection is screened. As a
proof of concept, we showed that the array of the deletion strains
was sufficient to accurately predict a previously identified cellular
process targeted by the Shigella T3E OspF [12]. Next, we
employed the array of the deletion strains to investigate the
Xanthomonas campestris pv. vesicatoria T3E XopE2 for which no
cellular target was described. We found that XopE2 was
congruent to genes that were all involved in cell wall biogenesis
and organization, implying that XopE2 affected these processes.
Indeed, we showed that XopE2 caused sensitivity to the cell wall
stressing agents caffeine and SDS. Subsequently, we found that
XopE2 affected the ER stress response, which is tightly linked
to cell wall organization and biogenesis [34,35]. Thus, we
demonstrated the applicability of our approach for studying the
functions and targets of bacterial T3Es.
Our approach has several advantages over screening the yeast
null deletion strain collection. First, it is simple, convenient and
economical, requiring less than 10 days to complete a full screen
with relatively few plates. Second, working with a single 96-well
plate simplifies the analysis of the results and allows for more
repetitions to be made. Importantly, in contrast to previous
approaches, our approach does not necessitate the use of a robot,
lowering the initial investment required for performing the screen
Table 2. GO attributes enriched among the genes congruent
to XopE2.
Rank N
a X
b LOD
c p-Value GO Attribute
1 12 113 2.571 7.3E-15 cellular cell wall organization
2 12 113 2.571 7.3E-15 external encapsulating structure
organization
3 12 113 2.571 7.3E-15 cell wall organization
4 12 124 2.523 2.4E-14 cellular cell wall organization or biogenesis
5 12 124 2.523 2.4E-14 cell wall organization or biogenesis
6 11 106 2.086 6.3E-13 site of polarized growth
7 3 8 2.032 1.7E-05 cell wall chitin metabolic process
8 7 29 1.984 2.0E-10 incipient cellular bud site
9 9 56 1.952 7.3E-12 mating projection tip
10 9 59 1.924 1.2E-11 cell projection part
11 3 10 1.897 3.6E-05 cell wall polysaccharide metabolic process
12 8 50 1.844 2.1E-10 ER-nucleus signaling pathway
13 3 11 1.842 4.9E-05 aminoglycan metabolic process
14 3 11 1.842 4.9E-05 chitin metabolic process
15 3 13 1.750 8.5E-05 cell wall macromolecule metabolic process
16 5 31 1.642 1.3E-06 cellular bud tip
17 7 65 1.559 8.1E-08 cellular bud neck
18 9 128 1.530 1.6E-08 intracellular signaling pathway
19 9 136 1.500 2.8E-08 signaling pathway
20 9 136 1.500 2.8E-08 signaling
21 12 768 1.452 1.2E-04 cellular component organization
22 7 89 1.403 7.5E-07 sexual reproduction
23 5 55 1.356 2.5E-05 actin filament-based process
24 7 114 1.281 4.1E-06 reproduction
Results obtained from the FuncAssociate 2.0 web application.
aN - the number of congruent genes that have the GO attribute.
bX - total number of interacting genes covered by our array that have the GO
attribute.
cLOD - Logarithm (base 10) of the odds ratio.
doi:10.1371/journal.pone.0027698.t002
Figure 4. XopE2 causes sensitivity to cell wall stressing agents. The indicated yeast strains containing pGML10, either empty or encoding
XopE2, were normalized to OD600=1.0 and spotted in 10-fold serial dilutions on repressing (2% glucose) and inducing (2% galactose and 1%
raffinose) plates with the indicated cell wall stressing agents: caffeine 7 mM; SDS 0.003% (w/v); Congo red (CR) 100 mgm l
21; calcofluor white (CFW)
100 mgm l
21.
doi:10.1371/journal.pone.0027698.g004
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proteins that function inside the host cell. Nevertheless, using
robotic plating, it is possible to simultaneously screen a large
repertoire of effectors, an intriguing possibility in light of the
growing number of bacterial proteins identified as effectors.
It should be noted that our approach is suitable for studying
bacterial T3Es that target conserved eukaryotic processes found in
yeast. It is not expected to yield significant results for T3Es that
affect specific processes that cannot be found in yeast.
The hypersensitive deletion strains identified in the screen can
be used in additional ways. First, the hypersensitive deletion strains
can be used to screen for genes, which upon over-expression,
suppress the growth inhibition phenotype caused by the T3Es.
Finding such suppressors can assist in identifying the cellular
processes that are targeted by the T3Es. Second, the hypersen-
sitive deletion strains can be used to classify T3Es of various
pathogens into functional groups, laying the foundation for future
study of ‘‘functional effector families’’.
Several factors affected our selection of the expression vector.
Our system employs the GAL1/10 promoter, a strong promoter
whose activity is regulated by the carbon source in the medium.
An important feature of the GAL1/10 promoter is that it does not
require the use of modified yeast strains, which simplified the
construction of the array. The use of an inducible expression
vector enabled us to perform the transformation step under
conditions in which the expression of the bacterial effector is
repressed, grow the transformed cells to saturation and only then
spot them on inducing and repressing plates. In this way, we
eliminated the effect of variations in transformation efficiency
between deletion strains. Another important factor that influenced
our selection of the expression vector was the number of copies of
the effector gene in the cell. It was previously suggested that high-
level expression of the bacterial effector (when using a 2 micron
vector) might result in non-specific activity of the effector [18].
Our system uses a centromere-containing vector to obtain low-
level expression of the bacterial effector and thus to increase the
specificity of the assay. The expression vector that we use also
contains a single myc tag, which allows to monitor the expression
of the effector in the cell. The tag is fused to the C-terminal tail of
the effector and owing to its short size it is not likely to affect the
expression or the function of the effector.
Our approach requires the transformation of the array of
deletion strains with the vector encoding the bacterial effector.
One way to avoid this step is to transform a single yeast strain with
the vector encoding the bacterial effector, and by mating and
meiosis to transfer the vector to the deletion strains. However, this
approach, known as the synthetic genetic array (SGA) methodol-
ogy [38,39], is much slower, requiring at least two weeks, not
including the time required for the transformation of the starting
strain [40,41]. Nevertheless, the SGA methodology should be
considered when a large number of bacterial T3Es are screened
simultaneously, ideally with the aid of a robot. Another mating-
based approach, which is expected to be much faster than the
SGA methodology, is called selective ploidy ablation (SPA) [42].
This approach employs a universal plasmid donor strain that
contains conditional centromeres on every chromosome. The
plasmid-bearing donor strain is mated to a recipient, followed by
removal of all donor-strain chromosomes, producing a haploid
strain containing the transferred plasmid. One limitation of the
Figure 5. XopE2 does not affect the activation of the CWI
pathway. Caffeine-mediated activation of a RLM1-regulated b-
galactosidase reporter in yeast expressing XopE2 or an empty
expression vector. Activity is reported as percentage of Miller units.
100% activity is set as the activity in yeast treated with 7 mM caffeine in
the absence of XopE2. Data represent the mean and standard error
(n=4). The assay was repeated three times with similar results.
doi:10.1371/journal.pone.0027698.g005
Figure 6. XopE2 affects the ER stress response. A. The indicated
strains were grown overnight in repressing medium (2% glucose). Cells
were then washed, normalized to OD600=1.0, and spotted in 10-fold
serial dilutions on repressing (2% glucose) and inducing (2% galactose
and 1% raffinose) plates with 0.165 mgm l
21 tunicamycin (Tm; upper
panels) or 70 mM 2-deoxy-D-glucose (2-DG; lower panels). B. DTT-
mediated activation of a UPRE-regulated b-galactosidase reporter.
XopE2 was expressed in wild-type cells that were treated or not with
2 mM DTT. The response of the Dire1 strain was used as a control.
Activity is reported as percentage of Miller units. 100% activity is set as
the activity in yeast treated with DTT in the absence of XopE2. Data
represent the mean and standard error (n=4). The assays were
repeated three times with similar results.
doi:10.1371/journal.pone.0027698.g006
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growth on galactose, which induces the expression of the bacterial
effector in our system.
Finally, although we concentrated our work on bacterial T3Es,
our approach can be easily employed to study other types of
virulence proteins that function inside host cells, such as bacterial
type IV and type VI secreted effectors, fungal effectors and viral
proteins. In conclusion, the approach presented in this work
provides an excellent platform for studying the functions and
cellular targets of bacterial effectors and other virulence proteins.
Materials and Methods
Synthetic lethal interaction and phenotypic data
SL interactions and phenotypic data were extracted from the
Saccharomyces Genome Database (http://www.yeastgenome.org,
downloaded on 19 April 2011). It was assumed that all SL
interactions were symmetric. The database contains 10,438
unique SL interactions between 2,795 genes (435 genes interact
only with genes marked in the Saccharomyces Genome Database as
inviable and were not taken into account).
Media and bacterial and yeast strains
Bacteria used in this study are E. coli DH12S. Bacteria were
grown in Luria-Bertani broth supplemented with 100 mg/ml
ampicillin at 37uC [43]. Yeast strains used in this study are
BY4741 (MATa his3D1 leu2D0 met15D0 ura3D0) and the BY-series
deletion strains [44] of the genes listed in Table S1. Yeast were
grown at 30uC in YPD medium (1% yeast extract, 2% peptone,
2% glucose) or in selective synthetic complete media lacking uracil
and/or leucine to maintain plasmids, and supplemented with 2%
glucose or 2% galactose and 1% raffinose as carbon sources [45].
96-well microtiter plate yeast transformation protocol
Glycerol stocks of the yeast haploid deletion strains were plated
onto YPD agar and incubated at 30uC for 2 days. Single colonies
were picked into a round-bottom 96-well microtiter plate
containing 150 ml of YPD in each well. The microtiter plate was
incubated overnight at 30uC. Next, the microtiter plate was
centrifuged for 5 minutes at 700 g and the supernatant was
removed by a single shake of the plate into a large sink. Cells were
resuspended with 100 ml/well DDW using an 8-channel multi-
pipettor, and 25 ml from each well were transferred to a new
round-bottom 96-well microtiter plate containing 75 ml/well
DDW. The microtiter plate was centrifuged for 5 minutes at
700 g and the supernatant was removed. Cells were resuspended in
50 ml of a freshly prepared transformation mix (0.3 M LiAc
pH,7.5, 1 mg/ml boiled single strand Salmon sperm DNA,
4 ng/ml plasmid DNA) [46]. After resuspension, 100 ml of 50%
(w/v) PEG 3350 were added to each well with truncated tips and
mixed with the transformation mix. The microtiter plate was then
placed in a plastic bag and incubated at 42uC for 2 hours with
constant shaking. After incubation, 10 ml/well DMSO were added
and the plate was placed again in a plastic bag and incubated at
42uC for 30 minutes with constant shaking. Following incubation,
the plate was centrifuged at 1500 g for 10 minutes and the
supernatant removed as described above. The plate was washed 3
times by addition of 100 ml/well DDW followed by centrifugation
at 700 g for 5 minutes and removal of the supernatant to dispose of
residual PEG 3350. Finally, cells were resuspended in 10 ml/well
DDW, and transformations were spotted onto selective synthetic
complete media lacking leucine and supplemented with 2%
glucose [45]. Plates were incubated at 30uC for 2–3 days.
Identification of processes targeted by XopE2 using the
array of deletion strains
The yeast strains of the array were transformed with pGML10
vector either empty or encoding a galactose inducible XopE2 [47].
Transformed cells were spotted in quadruplicates on both
repressing (2% glucose) and inducing (2% galactose and 1%
raffinose) media in Omni trays (Nunc, http://www.nuncbrand.
com) and were allowed to grow for 2–3 days. The spots from three
biological repetitions were digitally quantified using the Otsu’s
method [48] (see Fig. S3 for a summary of the quantification
procedure). The resulting values were used to determine which
deletion strains were hypersensitive to the expression of XopE2
(see Figs. S4 and S5 for examples of the data analysis). The
hypersensitive deletion strains were analyzed to identify congruent
genes, using yeast SL interactions data extracted from the
Saccharomyces Genome Database. The list of congruent genes was
used to identify potential cellular targets of XopE2, using the
FuncAssociate 2.0 web application (http://llama.mshri.on.ca/
funcassociate/) [22]. Similar analysis was performed for the
Shigella T3E OspF. The various procedures are described in Text
S1.
Spotting assays
BY4741 yeast strains, either wild-type or from the deletion
strain collection, were transformed with pGML10, either empty or
encoding XopE2. Cells were grown overnight in repressing
medium (2% glucose), washed and normalized to OD600=1.0,
and 10-fold or 5-fold serial dilutions, as indicated, were spotted
onto repressing and inducing (2% galactose and 1% raffinose)
media with or without the indicated stressing agents. Pictures were
taken after 2–3 days of growth at 30uC.
LacZ reporter activation assays
To determine activation of the CWI pathway, yeast containing
the RLM1-regulated lacZ reporter [12,29] and the pGML10
vector either empty or encoding XopE2 [47] were grown
overnight in selective media containing glucose (2%). Cultures
were washed, diluted and grown to OD600=0.5–0.8 in selective
media containing galactose (2%) and raffinose (1%). Cultures were
then supplemented with 7 mM caffeine or the equivalent volume
of water, and incubated at 30uC for 4 hours. After incubation,
cells were collected and subjected to a b-galactosidase activity
assay.
To determine activation of the UPR, yeast containing a UPRE-
regulated lacZ reporter [49] and the pGML10 vector either empty
or encoding XopE2 [47] were grown overnight in selective media
containing glucose (2%). Cultures were washed, diluted and grown
to OD600=0.5–0.8 in selective media containing galactose (2%)
and raffinose (1%). Cultures were then supplemented with 2 mM
DTT or the equivalent volume of water, and incubated at 30uC
for 4 hours. After incubation, cells were collected and subjected to
a b-galactosidase activity assay. Quantitative assays for b-
galactosidase activity were performed as described [50,51].
Supporting Information
Text S1 Supporting methods. The supporting methods
include additional information on the construction of the 96-well
plate, the screen for deletion strains hypersensitive to bacterial type
III effectors, analysis of the results from the screens, identification
of congruent genes, and identification of possible cellular targets
using FuncAssociate 2.0.
(PDF)
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plate. The Dsec22 strain (marked with an asterisk) was removed
from the analysis due to poor growth in several repetitions.
(TIF)
Figure S2 Validation of the hypersensitivity of the
deletion strains to XopE2. The indicated yeast strains
containing pGML10, either empty or encoding XopE2, were
normalized to OD600=1.0 and spotted in 5-fold serial dilutions on
repressing (2% glucose) and inducing (2% galactose and 1%
raffinose) plates.
(TIF)
Figure S3 Quantification of the results from the screen.
A, The plates are scanned and the images are edited to remove
margins, scratches and small stains. B, The images are partitioned
into a 16624 grid of squares, each containing a single spot. C,
The images are converted to binary images by computing the
global image threshold (Otsu’s method). D, The white pixels in
each square are counted and are saved for further analysis.
(TIF)
Figure S4 Calculation of the sensitivity of Dswf1 to
XopE2. A, Inducing/repressing ratio is calculated by dividing the
average number of white pixels of the quadruplicates on the
inducing plate by the average number of white pixels of the
quadruplicates on the repressing plate. The inducing/repressing
ratio of the wild-type strain is the average of all the transformations
of the wild-type strain. B, Growth ratio is calculated by dividing
the inducing/repressing ratio of each strain by the inducing/
repressing ratio of the wild-type strain. C, Relative growth ratio is
calculated by dividing the growth ratios of each deletion strain
containing XopE2 by the average of the growth ratio of the
deletion strain containing an empty vector.
(TIF)
Figure S5 Dbim1 is not hypersensitive to XopE2. See
Figure S4 for description of the calculation steps.
(TIF)
Table S1 The list of deletion strains used to construct
the array.
(PDF)
Table S2 Genes identified as congruent to OspF.
(PDF)
Table S3 GO attributes enriched among the genes
congruent to OspF.
(PDF)
Table S4 GO attributes enriched among the genes
congruent to XopE2 (including the congruent genes).
(PDF)
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